Dr. Neuman, CEO of BRD, was asked to attend the investigator’s meeting at Mass General Hospital in Boston, US to present the experience gained by BRD CRO from conducting 2 stem cell trials in ALS patients in Israel at the opening of the Brainstorm trial in the United States.

SPARK Program Education Forum
TEL-AVIV UNIVERSITY – OPENING EVENT FDA’s Expedited and Special Development and Review Programs Lecture by…
Read more >>